Drug interactions are reported among people who take Rituxan and Benadryl together. This review analyzes the effectiveness and drug interactions between Rituxan and Benadryl. It is created by eHealthMe based on reports of 3,136 people who take the same drugs from FDA and social media, and is updated regularly.
On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA and social media since 1977. Our tools are free and anonymous. 86 million people have used us. 300+ peer-reviewed medical journals have referenced our original studies. Start now >>>
Rituxan has active ingredients of rituximab. It is often used in rheumatoid arthritis. (latest outcomes from Rituxan 18,110 users)
Benadryl has active ingredients of diphenhydramine hydrochloride. It is often used in hypersensitivity. (latest outcomes from Benadryl 43,259 users)
On Sep, 17, 2016
3,136 people who take Rituxan, Benadryl are studied.
* Approximation only. Some reports may have incomplete information.
How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.
I have been losing,my hair for almost a month now. It falls out constantly in clumps. I have also had severe upset stomach. I was desperate to find answers, and I am so happy I found this website. I have been taking benadryl to prevent migraines and now believe this is what's causing the hair loss and stomach cramps. DOES THE HAIR GROW BACK WHEN YOU STOP TAKING BENADRYL???
Hi, I had CLL and took Rituxan and a year later I couldn't see. I had s MRI and they found lesions in the occipital lobe of my brain. My oncologist did a work up and had no clue as to what it may be. I finally went into NYC and had a brain biopsy and then they determined it was PML. That was in July 2014 and I was given weeks to months to live. My daughter took my all over the country to various doctors who gave us no hope. We then found Dr. Berger at the university of penn who finally said that these two medications maritzapine and mefloquine you have nothing to lose. I took them for the next several months and saw Dr. Berger monthly, things seemed to look better and he said there is a clinical trail at the National Institution of Health in Maryland he called his friend Dr. Avi Nath and I was a candidate for a tcell transfer which had to be approved by the FDA but over the next few months my lesions shrank and I regained my ability to walk much better, but never regained my eyesight. I'm still enrolled in the clinical study being that they can try to understand how and why I survived. Maybe they can help another person who is afflicted with this horrible disease.
On eHealthMe, Rituxan (rituximab) is often used to treat rheumatoid arthritis. Benadryl (diphenhydramine hydrochloride) is often used to treat hypersensitivity. Find out below the conditions the drugs are used for and how effective they are.
NOTE: The study is based on active ingredients and brand name. Other drugs that have the same active ingredients (e.g. generic drugs) are NOT considered.
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.